Critical upper airway obstruction in sporadic angioedema responding to C1-esterase inhibitor.

BMJ Case Rep

Division of Paediatric Allergy and Clinical Immunology, Department of Paediatrics, Montreal Children's Hospital, McGill University Health Center, Montreal, Canada.

Published: May 2013

We describe a case of recurrent oropharyngeal angioedema in a 16-year-old boy with a history of sickle cell disease and thrombocytopenia and with no family history of angioedema. Emergency treatment of angioedema with C1-esterase inhibitor (C1-INH) provided immediate relief, avoiding the placement of a surgical airway. Further evaluation has shown C1-INH to be normal in quantity and function, with normal complement studies during acute attacks. Genetic testing revealed no abnormality in the factor XII gene. Our case exemplifies that even in cases of sporadic angioedema, treatment with C1-INH may be an effective and life-saving management strategy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669871PMC
http://dx.doi.org/10.1136/bcr-2013-009616DOI Listing

Publication Analysis

Top Keywords

sporadic angioedema
8
c1-esterase inhibitor
8
angioedema
5
critical upper
4
upper airway
4
airway obstruction
4
obstruction sporadic
4
angioedema responding
4
responding c1-esterase
4
inhibitor describe
4

Similar Publications

Article Synopsis
  • Loiasis, caused by the Loa loa worm and affecting around 10 million people in Central Africa, presents challenges in diagnosis and treatment due to potential severe reactions to ivermectin used for other infections.
  • Diagnosis typically involves identifying adult worms or microfilariae in blood, but many infections are "occult," prompting the need for new diagnostic tools.
  • This study compared two serological rapid antibody tests for loiasis and onchocerciasis, evaluating their effectiveness in diagnosing infections among participants, revealing a high prevalence of both microfilaremia and symptoms related to loiasis.
View Article and Find Full Text PDF

Complex analysis of the national Hereditary angioedema cohort in Slovakia - Identification of 12 novel variants in gene.

World Allergy Organ J

March 2024

National Centre for Hereditary Angioedema, Clinic of Children and Adolescents, Clinics of Pulmonology and Phthisiology, Jessenius Faculty of Medicine, Comenius University in Bratislava, University Hospital in Martin, Slovakia.

Background: Hereditary angioedema (HAE) is a rare autosomal dominant genetic disease characterised by acute episodes of non-pruritic skin and submucosal swelling caused by increase in vascular permeability.

Objective: Here we present the first complex analysis of the National HAE Slovakian cohort with the detection of 12 previously un-published genetic variants in gene.

Methods: In patients diagnosed with hereditary angioedema caused by deficiency or dysfunction of C1 inhibitor (C1-INH-HAE) based on clinical manifestation and complement measurements, gene was tested by DNA sequencing (Sanger sequencing/massive parallel sequencing) and/or multiplex ligation-dependent probe amplification for detection of large rearrangements.

View Article and Find Full Text PDF

Hereditary angioedema is a rare, autosomal dominant genetic disorder that leads to sporadic episodes of swelling, which can affect any part of the body. With a prevalence of 1 in 10,000 to 1 in 50,000, there are other, more common causes of angioedema. Differentiating between bradykinin-mediated and histamine-mediated causes of swelling remains a major challenge.

View Article and Find Full Text PDF

Characteristics of patients with C1 esterase inhibitor deficiency: a single center study.

Eur Ann Allergy Clin Immunol

March 2021

Division of Pediatric Immunology, Department of Pediatrics, Hacettepe University Medical School, Ankara, Turkey.

Hereditary angioedema (HAE) is a primary complement factor deficiency, characterized by recurrent submucosal/subcutaneous swelling episodes. SERPING1 gene defects encoding C1 esterase inhibitor (C1INH) are responsible from the disease. Fifteen patients with HAE are retrospectively evaluated in this study.

View Article and Find Full Text PDF

Amlodipine-induced angioedema: An unusual complication of a common medication.

Allergy Rhinol (Providence)

April 2018

Department of Internal Medicine, Saint Vincent Hospital, Worcester, Massachusetts.

Hypersensitivity reactions to dihydropyridine calcium channel blockers (CCB) are exceedingly rare, although sporadic reports of isolated angioedema seem to be gradually increasing in frequency. We present a case of angioedema likely triggered by amlodipine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!